Roche ROP 2.63%increase; up pointing triangle confirmed its full-year guidance after reporting a first-quarter rise in sales driven by high demand for its innovative medicines and diagnostics.

The Swiss pharmaceutical giant said Thursday that sales rose 6% at constant currency to 14.72 billion Swiss francs ($18.76 billion) for the first three months of the year. Analysts were expecting group sales of 14.73 billion francs, according to a Visible Alpha consensus.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8